Thousands of cancer sufferers are set to be denied a 'miracle' drug on the NHS that is routinely used in virtually every other Western country.
The Government's rationing body says Avastin is not cost-effective despite evidence that it can prolong the lives of bowel cancer patients by more than two years.
The final decision is due next month, but NICE, the National Institute for Health and Clinical Excellence, has already made clear the cost breaches its threshold for NHS use.
'Miracle': Barbara Moss said treatment with Avastin transformed her life
Ten times as many patients get Avastin paid for by private health insurers than on the health service.
The NICE veto would represent the first major test of a Tory pledge to fund all cancer drugs if the party wins the General Election.
No comments:
Post a Comment
Spamming will be removed.
Due to spamming. Comments need to be moderated. Your post will appear after moderated regardless of your views as long as they are not abusive in nature. Consistent abusive posters will not be viewed but deleted.
Note: Only a member of this blog may post a comment.